Skip to main content
Article thumbnail
Location of Repository

Measurement of tumor necrosis factor-α, leukotriene B4, and interleukin 8 in the exhaled breath condensate in patients with acute exacerbations of chronic obstructive pulmonary disease

By Fanny WS Ko, Ting-Fan Leung, Gary WK Wong, Jenny Ngai, Kin W To, Susanna Ng and David SC Hui
Topics: Original Research
Publisher: Dove Medical Press
OAI identifier: oai:pubmedcentral.nih.gov:2672793
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (1997). Airway infl ammation in COPD assessed by sputum levels of interleukin-8.
    2. (1987). American Thoracic Society. Standardization of spirometry –
    3. (2002). Analysis of exhaled breath condensate for monitoring airway infl ammation. Trends Pharmacol Sci,
    4. (2005). Analysis of growth factors and infl ammatory cytokines in exhaled breath condensate from asthmatic children. Int Arch Allergy Immunol,
    5. (2007). Are exhaled breath condensates useful in monitoring asthma? Curr Allergy Asthma Rep,
    6. (2000). Bronchial infl ammation in acute bacterial exacerbations of chronic bronchitis: the role of leukotriene B4.
    7. (1996). Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma.
    8. (1998). Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.
    9. (1997). Effects of inhaled and oral glucocorticoids on infl ammatory indices in asthma and COPD.
    10. (2005). Exhaled breath condensate cytokine patterns in chronic obstructive pulmonary disease. Respir Med,
    11. (2006). Exhaled breath condensate levels of 8-isoprostane, growth related oncogene alpha and monocyte chemoattractant protein-1 in patients with chronic obstructive pulmonary disease. Respir Med,
    12. (2006). Exhaled breath condensate levels of eotaxin and macrophage-derived chemokine in stable adult asthma patients. Clin Exp Allergy,
    13. (2002). Exhaled breath condensate: an evolving tool for noninvasive evaluation of lung disease.
    14. (2005). Exhaled breath condensate: methodological recommendations and unresolved questions.
    15. (2006). Expression of primingassociated cellular markers on neutrophils during an exacerbation of COPD. Respir Med,
    16. (2006). Global Initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Updated
    17. (2001). Granulocyte infl ammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease.
    18. (2003). Increased infl ammatory markers in the exhaled breath condensate of cigarette smokers.
    19. (1980). Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes.
    20. (2005). Markers of infl ammation and oxidative stress in exacerbated chronic obstructive pulmonary disease patients. Respir Med,
    21. (2004). Markers of infl ammation in exhaled breath condensate of young healthy smokers.
    22. (1989). Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.
    23. (1999). Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial.
    24. (2006). Pulmonary biomarkers in chronic obstructive pulmonary disease.
    25. (2000). Randomised, double blind, placebo controlled study of fl uticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial.
    26. (2000). Relation of sputum infl ammatory markers to symptoms and lung function changes in COPD exacerbations.
    27. (2002). Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations.
    28. (2006). Role of TNFalpha in pulmonary pathophysiology. Respir Res, 7:125. National Heart, Lung and Blood Institute, World Health Organization.
    29. Statement of the American Thoracic Society. Am Rev Respir Dis,
    30. (1986). Statistical methods for assessing agreement between two methods of clinical measurement.
    31. (2005). Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev,
    32. (2007). Systemic cytokines, clinical and physiological changes in patients hospitalized for exacerbation of COPD.
    33. (2004). The promise and perils of exhaled breath condensates.
    34. (2005). Tumor necrosis factor-alpha overexpression in lung disease: a single cause behind a complex phenotype.
    35. (2006). Updated spirometric reference values for adult Chinese in Hong Kong and implications on clinical utilization.
    36. (2005). Use of exhaled nitric oxide measurements to guide treatment in chronic asthma.
    37. (2006). Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.